apatinib + irinotecan
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for apatinib + irinotecan, covering 2019-11-13 to 2019-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Apatinib Plus Irinotecan as Second-line Treatment in AGC or EGJA [Phase 2]